Rapid COVID+Flu (A+B) Combo test
The Sars-CoV-2 & Influenza A+B Combo Rapid Test
is a rapid chromatographic immunoassay for the qualitative detection of Sars-CoV-2 and Influenza A/B antigens in human nasopharyngeal swab, or oropharyngeal swab specimen in
individuals who are suspected of respiratory viral infection consistent with COVID-19 and/or flu.
The Sars-CoV-2 virus belong to the β genus coronaviruses and the cause of COVID-19 which is an acute respiratory infectious disease. People are generally susceptible. Currently, the patients infected by the Sars-CoV-2 virus are the main source of infection; asymptomatic infected people can also be an infectious source. Based on the current epidemiological investigation, the incubation period is mostly 3 to 7 days, and could be up to 14 days in some individuals. The main manifestations include fever, fatigue and dry cough. Nasal congestion, runny nose, sore throat, myalgia and diarrhea are found in a few cases.
Influenza viruses are the pathogens that cause influenza. Influenza is an acute respiratory infection caused by influenza A, B viruses, which is highly contagious and spread fast, short incubation period, high incidence. Influenza A virus often appears in an epidemic form, which can cause a worldwide influenza pandemic. Influenza B virus often causes local outbreaks and does not cause a worldwide pandemic of influenza.
The Sars-CoV-2 & Influenza A+B Combo Rapid Test is designed as a simple tool in detection of Sars-CoV-2. influenza A and influenza B for regular clinical diagnosis.